Home

Investor Relations

Company Profile

Corporate Governance

Management Team

Board of Directors

Committee Composition

Stock Information

Analysts Coverage

Email Alerts

Press Room

Annual Report and Proxy

SEC Filings

Investor FAQs

Shareholder Briefcase

 

 

Committee Composition

Display all Bios

Committee Chair = Chair Committee Member = Member
  Audit Nominating and Governance Compensation
Luke Evnin Ph.D   Member of Nominating and Governance Committee Member of Compensation Committee
Catherine Friedman Committee Chair for Audit Committee    
Carl Goldfischer M.D.   Committee Chair for Nominating and Governance Committee  
Bobby I. Griffin   Observer Rights Member of Compensation Committee
Donald C. Harrison M.D. Member of Audit Committee    
Paul H. Klingenstein Member of Audit Committee Member of Nominating and Governance Committee  
Nicholas L. Teti Jr.      

Nicholas L. Teti, Jr. has served as one of our directors since May 2007. Mr. Teti is currently an independent consultant serving public and private health care companies. Mr. Teti 's most recent assignment was Chief Executive Officer of Den-Mat, a dental aesthetics company focused on developing non-invasive techniques, a position he held from January 2008 until March 2009. Since June 2006, he has also served as Chairman of the Board of Isolagen, Inc., a biotechnology company which develops emergent, novel skin and tissue rejuvenation technologies. From June 2006 to January 2008, Mr. Teti was Chief Executive Officer of Isolagen. From 2001 to 2006, Mr. Teti was President and Chief Executive Officer of Inamed Corporation, a healthcare products manufacturer focused on marketing breast implants, dermal fillers to correct facial wrinkles, and devices to treat severe and morbid obesity, including the LAP-BAND Adjustable Gastric Banding System. Mr. Teti served on the board of Inamed during 2001 and was Chairman of the Board from 2002 to 2006. Prior to that, Mr. Teti spent 25 years at DuPont and DuPont Merck where he held a number of senior management positions including President and CEO of DuPont Pharmaceuticals.

Jon T. Tremmel     Committee Chair for Compensation Committee


 

 

Home | What is VBLOC® Therapy? | Why VBLOC® Therapy?
Bariatric Weight Loss Surgery | Investors | Careers | Privacy Policy

EnteroMedics - 2800 Patton Road - St. Paul, MN 55113
CAUTION: Investigational device. Limited by Federal law to investigational use.
This page revised May 2009.